Evaluation of the Benefits of De-Escalation for Patients with Sepsis in the Emergency Intensive Care Unit
Takahiro Niimura(Tokushima University), Keisuke Ishizawa(Tokushima University Hospital), Kenshi Takechi(Matsuyama University), Yoshito Zamami(Tokushima University Hospital), Kanako Nagao(Okayama University), Naoto Okada(Yamaguchi University Hospital), Mitsuhiro Goda(Okayama University), Toshihiro Koyama(Okayama University), Hironori Nakura(Okayama University), Masaki Imanishi(Tokushima University Hospital), Masayuki Chuma(Nihon University), Hidenori Sagara(Matsuyama University), Toshiaki Sendo(Okayama University Hospital), Masafumi Kayano(Tokushima University Hospital), Tadashi Koga(Shin Nippon Biomedical Laboratories (Japan)), Toru Imai(Nihon University Itabashi Hospital)
Cited by 12
Related Papers
Factors Associated With Immune Checkpoint Inhibitor–Related Myocarditis
|JAMA Oncology|2019|134
Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study
|Clinical Therapeutics|2018|99
Royal Jelly Ameliorates Insulin Resistance in Fructose-Drinking Rats
|Biological and Pharmaceutical Bulletin|2008|88
Trends in Polypharmacy in Japan: A Nationwide Retrospective Study
|Journal of the American Geriatrics Society|2018|81